EntrepreneurialCheck
Kursad Araz estimated net worth profile

Kursad Araz net worth

Kursad Araz Net Worth 2026 (Estimated) · CTO at Correlia Biosystems · YC W18
est. wealth $22K

Quick answer

Kursad Araz's estimated net worth is $22K (range $16K – $34K) as of 2026. Kursad Araz is CTO at Correlia Biosystems. Correlia Biosystems valuation.

Kursad Araz is CTO at Correlia Biosystems (YC W18). Independent Entrepreneurial Check model estimate from public YC data.

At a glance

NameKursad Araz
RoleCTO
CompanyCorrelia Biosystems
YC batchW18
Est. company val$1.0M
Assumed ownership2.2%
Est. paper wealth / net worth$22K
$16K – $34K
  • Company status: Inactive
  • Education: PhD in Bioengineering from Stanford University
  • Region: United States of America
  • Industries: Healthcare, Diagnostics
  • Team size: 16
  • Website: http://www.correliabio.com

Who is Kursad Araz?

Kursad Araz is a founder of Correlia Biosystems, a company focused on biotechnology solutions.

Highlights:

  • Stanford University
  • University of California, Berkeley
  • Y Combinator W18

About Correlia Biosystems

Correlia Biosystems is a UC Berkeley spinoff company based in Berkeley, CA. Correlia develops innovative microscale tools that accelerate rapid quantification of biomolecules.

Our versatile "SimpleScan" technology opens up new biological questions from one microliter of sample, with rapid results that allow for dynamic monitoring of protein expression profiles (rather than simple end-point measurement)....

FAQ: Kursad Araz net worth and Correlia Biosystems valuation

What is Kursad Araz's net worth?

Kursad Araz's estimated net worth is $22K (range $16K – $34K) as of 2026. Kursad Araz is CTO at Correlia Biosystems. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.

What is Correlia Biosystems valuation?

Correlia Biosystems's estimated valuation on Entrepreneurial Check is $1.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.

What is Kursad Araz's role?

Kursad Araz is CTO at Correlia Biosystems, a Y Combinator-backed startup (batch W18).